Dianat-Moghadam H - Search Results

1

MicroRNAs regulating Wnt signaling pathway in colorectal cancer: biological implications and clinical potentials.

Beni FA, Kazemi M, Dianat-Moghadam H, Behjati M. Beni FA, et al. Funct Integr Genomics. 2022 Dec;22(6):1073-1088. doi: 10.1007/s10142-022-00908-x. Epub 2022 Oct 20. Funct Integr Genomics. 2022. PMID: 36264397 Review.

2

Correction to: MicroRNAs regulating Wnt signaling pathway in colorectal cancer: biological implications and clinical potentials.

Beni FA, Kazemi M, Dianat-Moghadam H, Behjati M. Beni FA, et al. Funct Integr Genomics. 2022 Dec;22(6):1495. doi: 10.1007/s10142-022-00919-8. Funct Integr Genomics. 2022. PMID: 36422750 No abstract available.

3

Immunotherapies targeting tumor vasculature: challenges and opportunities.

Dianat-Moghadam H, Nedaeinia R, Keshavarz M, Azizi M, Kazemi M, Salehi R. Dianat-Moghadam H, et al. Front Immunol. 2023 Sep 1;14:1226360. doi: 10.3389/fimmu.2023.1226360. eCollection 2023. Front Immunol. 2023. PMID: 37727791 Free PMC article. Review.

4

LXR inhibitor SR9243-loaded immunoliposomes modulate lipid metabolism and stemness in colorectal cancer cells.

Dianat-Moghadam H, Abbasspour-Ravasjani S, Hamishehkar H, Rahbarghazi R, Nouri M. Dianat-Moghadam H, et al. Med Oncol. 2023 Apr 24;40(6):156. doi: 10.1007/s12032-023-02027-4. Med Oncol. 2023. PMID: 37093287

5

Immune evader cancer stem cells direct the perspective approaches to cancer immunotherapy.

Dianat-Moghadam H, Mahari A, Salahlou R, Khalili M, Azizi M, Sadeghzadeh H. Dianat-Moghadam H, et al. Stem Cell Res Ther. 2022 Apr 8;13(1):150. doi: 10.1186/s13287-022-02829-9. Stem Cell Res Ther. 2022. PMID: 35395787 Free PMC article. Review.

6

Implications of Fibroblast Growth Factors (FGFs) in Cancer: From Prognostic to Therapeutic Applications.

Dianat-Moghadam H, Teimoori-Toolabi L. Dianat-Moghadam H, et al. Curr Drug Targets. 2019;20(8):852-870. doi: 10.2174/1389450120666190112145409. Curr Drug Targets. 2019. PMID: 30648505 Review.

7

Engaging stemness improves cancer immunotherapy.

Dianat-Moghadam H, Sharifi M, Salehi R, Keshavarz M, Shahgolzari M, Amoozgar Z. Dianat-Moghadam H, et al. Cancer Lett. 2023 Feb 1;554:216007. doi: 10.1016/j.canlet.2022.216007. Epub 2022 Nov 14. Cancer Lett. 2023. PMID: 36396102 Review.

8

Resveratrol as an antitumor agent for glioblastoma multiforme: Targeting resistance and promoting apoptotic cell deaths.

Karkon-Shayan S, Aliashrafzadeh H, Dianat-Moghadam H, Rastegar-Pouyani N, Majidi M, Zarei M, Moradi-Vastegani S, Bahramvand Y, Babaniamansour S, Jafarzadeh E. Karkon-Shayan S, et al. Among authors: dianat moghadam h. Acta Histochem. 2023 Aug;125(6):152058. doi: 10.1016/j.acthis.2023.152058. Epub 2023 Jun 17. Acta Histochem. 2023. PMID: 37336070 Review.

9

Application of cell free DNA in ART.

Alizadegan A, Dianat-Moghadam H, Shadman N, Nouri M, Hamdi K, Ghasemzadeh A, Akbarzadeh M, Sarvarian P, Mehdizadeh A, Dolati S, Yousefi M. Alizadegan A, et al. Placenta. 2022 Mar 24;120:18-24. doi: 10.1016/j.placenta.2022.02.003. Epub 2022 Feb 9. Placenta. 2022. PMID: 35158147 Review.

10

Natural killer cell-based immunotherapy: From transplantation toward targeting cancer stem cells.

Dianat-Moghadam H, Rokni M, Marofi F, Panahi Y, Yousefi M. Dianat-Moghadam H, et al. J Cell Physiol. 2018 Jan;234(1):259-273. doi: 10.1002/jcp.26878. Epub 2018 Aug 25. J Cell Physiol. 2018. PMID: 30144312 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38 results

Search Page

Filters